Cargando…

Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish

Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lidong, Li, Xueting, He, Mingyue, Wang, Qingchen, Chen, Ce, Li, Fangshun, Li, Bingsheng, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045075/
https://www.ncbi.nlm.nih.gov/pubmed/36978831
http://dx.doi.org/10.3390/antiox12030583
_version_ 1784913509087182848
author Yu, Lidong
Li, Xueting
He, Mingyue
Wang, Qingchen
Chen, Ce
Li, Fangshun
Li, Bingsheng
Li, Li
author_facet Yu, Lidong
Li, Xueting
He, Mingyue
Wang, Qingchen
Chen, Ce
Li, Fangshun
Li, Bingsheng
Li, Li
author_sort Yu, Lidong
collection PubMed
description Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium supplements and iron chelators. However, simple calcium supplementation is not effective, and it does not have a good therapeutic effect. Oxidative stress is one of the triggers for osteoporosis. Therefore, the study focuses on the antioxidant aspect of osteoporosis treatment. The present work revealed that antioxidant carboxymethyl chitosan-based carbon dots (AOCDs) can effectively treat iron overload osteoporosis. More interestingly, the functional modification of AOCDs by doping calcium gluconate (AOCDs:Ca) is superior to the use of any single component. AOCDs:Ca have the dual function of antioxidant and calcium supplement. AOCDs:Ca effectively improve the bioavailability of calcium and achieve ultra-low concentration calcium supplement for the treatment of iron-induced osteoporosis in zebrafish.
format Online
Article
Text
id pubmed-10045075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100450752023-03-29 Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish Yu, Lidong Li, Xueting He, Mingyue Wang, Qingchen Chen, Ce Li, Fangshun Li, Bingsheng Li, Li Antioxidants (Basel) Article Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium supplements and iron chelators. However, simple calcium supplementation is not effective, and it does not have a good therapeutic effect. Oxidative stress is one of the triggers for osteoporosis. Therefore, the study focuses on the antioxidant aspect of osteoporosis treatment. The present work revealed that antioxidant carboxymethyl chitosan-based carbon dots (AOCDs) can effectively treat iron overload osteoporosis. More interestingly, the functional modification of AOCDs by doping calcium gluconate (AOCDs:Ca) is superior to the use of any single component. AOCDs:Ca have the dual function of antioxidant and calcium supplement. AOCDs:Ca effectively improve the bioavailability of calcium and achieve ultra-low concentration calcium supplement for the treatment of iron-induced osteoporosis in zebrafish. MDPI 2023-02-26 /pmc/articles/PMC10045075/ /pubmed/36978831 http://dx.doi.org/10.3390/antiox12030583 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yu, Lidong
Li, Xueting
He, Mingyue
Wang, Qingchen
Chen, Ce
Li, Fangshun
Li, Bingsheng
Li, Li
Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title_full Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title_fullStr Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title_full_unstemmed Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title_short Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
title_sort antioxidant carboxymethyl chitosan carbon dots with calcium doping achieve ultra-low calcium concentration for iron-induced osteoporosis treatment by effectively enhancing calcium bioavailability in zebrafish
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045075/
https://www.ncbi.nlm.nih.gov/pubmed/36978831
http://dx.doi.org/10.3390/antiox12030583
work_keys_str_mv AT yulidong antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT lixueting antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT hemingyue antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT wangqingchen antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT chence antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT lifangshun antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT libingsheng antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish
AT lili antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish